A team of Bascom Palmer Eye Institute and University of Miami researchers have received an award to fund the procurement, ...

Nocturnal intraocular pressure (IOP) profiling has shown that the peak IOP usually occurs at night, particularly in patients ...

The global glaucoma treatment market is projected to grow from USD 5.7 billion in 2022 to USD 8.0 billion by 2033, at a CAGR ...

The AAO has stated that the safest way to change eye color is the use of colored contact lenses, which should only be worn as ...

Glaucoma is the second leading cause of blindness worldwide, and students here in Champaign-Urbana at Carle Illinois College of Medicine are busy engaging with the offerings of this new training lab.

Glaukos Corporation GKOS has witnessed strong momentum in the year-to-date period. Shares of the company have surged 77.9% ...

Eye diseases like glaucoma, cataracts, and conjunctivitis are some of the more common types. Find eye disease awareness and ...

For patients with African ancestry, low body mass index may be a risk factor for increased primary open-angle glaucoma. Among people with African ancestry, body mass index lower than 18.5 (low BMI) is ...

SpyGlass Pharma completed enrollment in a Phase 1/2 trial evaluating its drug delivery platform for glaucoma and ocular ...

Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of glaucoma and retinal ...

SpyGlass prepares for End of Phase II meeting with the FDA to advance its Drug Delivery Platform into Phase III pivotal studiesInnovative ...